Bringing 5-FU monitoring home: microsampling as the potential next step beyond DPD deficiency screening

Expert Opinion on Drug Metabolism & Toxicology 2026

View at publisher
Authors: Manon Launay, Antonin Schmitt, Joseph Ciccolini
DOI: 10.1080/17425255.2026.2615387
Cited by: 1
References: 13

Abstract

Fluoropyrimidines (FP), such as 5-FluoroUracil (5-FU), still remain widely used, mainly in digestive and breast cancers. Approximately 85% of an administered dose is metabolized by the dihydropyrim...

Fields of Study & Subjects

Biosimilars and Bioanalytical Methods Immunodeficiency and Autoimmune Disorders Blood disorders and treatments

Publication details

Journal / source
Expert Opinion on Drug Metabolism & Toxicology
Publisher
Informa UK Limited
Volume
22
Issue
1
Pages
1–3
Publication date
2 January 2026
Language
EN